Related references
Note: Only part of the references are listed.Randomized, multicenter, phase IIB study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: Raltitrexed plus oxaliplatin plus radiotherapy versus cisplatin+5-fluorouracil plus radiotherapy
Vincenzo Valentini et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy
G. Lezoche et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2008)
Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival
R. Rosenberg et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction:: The MUNICON phase II trial
Florian Lordick et al.
LANCET ONCOLOGY (2007)
Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer
J. -P. Machiels et al.
ANNALS OF ONCOLOGY (2007)
A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy - Implications for sphincter preservation
Jose G. Guillem et al.
ANNALS OF SURGERY (2007)
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction
Katja Ott et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography
Francesco Stipa et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?
R Hughes et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2006)
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer
C Rödel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer
CJ Hoekstra et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: Continued experience of a phase I trial in rectal cancer patients
CG Willett et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer
N Avril et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy:: Is there a benefit in using functional imaging?
T Denecke et al.
EUROPEAN RADIOLOGY (2005)
Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point
JG Guillem et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer
JG Guillem et al.
ANNALS OF SURGERY (2005)
How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?
CC Chen et al.
DISEASES OF THE COLON & RECTUM (2005)
Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival
A Habr-Gama et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2005)
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: A means for determining longterm outcomes of rectal cancer
JG Guillem et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2004)
Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients
M Bonnen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome
S Pucciarelli et al.
DISEASES OF THE COLON & RECTUM (2004)
Preoperative versus postoperative chemoradiotherapy for rectal cancer
R Sauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: Results of a prospective trial
K Ott et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®)
S Stroobants et al.
EUROPEAN JOURNAL OF CANCER (2003)
A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision
J García-Aguilar et al.
DISEASES OF THE COLON & RECTUM (2003)
Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy
LY Ruo et al.
ANNALS OF SURGERY (2002)
Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival
MW Onaitis et al.
ANNALS OF SURGICAL ONCOLOGY (2001)
Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: Acute toxicity, tumor response, and sphincter preservation in three consecutive studies
V Valentini et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma - Pathologic findings and clinical implications
D Medich et al.
DISEASES OF THE COLON & RECTUM (2001)
Preoperative combined modality therapy for clinically resectable UT3 rectal adenocarcinoma
A Grann et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography
JG Guillem et al.
DISEASES OF THE COLON & RECTUM (2000)
Share Paper
